<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T19:24:36Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/6181" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/6181</identifier><datestamp>2024-11-01T02:56:41Z</datestamp><setSpec>com_2072_378071</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378097</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes</dc:title>
   <dc:creator>Vallespin, Elena</dc:creator>
   <dc:creator>Arias-Salgado, Elena G.</dc:creator>
   <dc:creator>Sánchez-Valdepeñas,  Carmen</dc:creator>
   <dc:creator>Giménez, Yari</dc:creator>
   <dc:creator>Navarro, Susana</dc:creator>
   <dc:creator>Díaz de Heredia Rubio, Maria Cristina</dc:creator>
   <dc:creator>Galvez, Eva</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Gálvez E] Servicio de Hematología y Oncología Pediátrica, Fundación de Investigación Biomédica, Hospital Infantil Universitario Niño Jesús, Madrid, Spain. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. [Vallespín E] Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, IDIPAZ, Madrid, Spain. Instituto de Investigaciones Biomédicas CSIC/UAM, IDIPaz, Madrid. [Arias-Salgado EG] Instituto de Investigaciones Biomédicas CSIC/UAM, IDIPaz, Madrid, Spain. [Sánchez-Valdepeñas C] Servicio de Hematología y Oncología Pediátrica, Fundación de Investigación Biomédica, Hospital Infantil Universitario Niño Jesús, Madrid, Spain. [Giménez Y, Navarro S] Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain. [Díaz de Heredia C] Grupo insuficiencias medulares de la SEHOP, Spain. Servei d’Oncologia i Hematologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Medul·la òssia - Malalties</dc:subject>
   <dc:subject>Seqüència de nucleòtids</dc:subject>
   <dc:subject>DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases::Bone Marrow Diseases</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Genetic Techniques::Sequence Analysis::High-Throughput Nucleotide Sequencing</dc:subject>
   <dc:subject>ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas::enfermedades de la médula ósea</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::técnicas genéticas::análisis de secuencias::secuenciación de nucleótidos de alto rendimiento</dc:subject>
   <dc:description>Síndromes d'insuficiència de la medul·la òssia; Seqüenciació de nova generació</dc:description>
   <dc:description>Síndromes de insuficiencia de la médula ósea; Secuenciación de próxima generación</dc:description>
   <dc:description>Bone Marrow Failure Syndromes; Next-generation Sequencing</dc:description>
   <dc:description>Inherited bone marrow failure syndromes (IBMFSs) are a group of congenital rare diseases characterized by bone marrow failure, congenital anomalies, high genetic heterogeneity, and predisposition to cancer. Appropriate treatment and cancer surveillance ideally depend on the identification of the mutated gene. A next-generation sequencing (NGS) panel of genes could be 1 initial genetic screening test to be carried out in a comprehensive study of IBMFSs, allowing molecular detection in affected patients. We designed 2 NGS panels of IBMFS genes: version 1 included 129 genes and version 2 involved 145 genes. The cohort included a total of 204 patients with suspected IBMFSs without molecular diagnosis. Capture-based targeted sequencing covered > 99% of the target regions of 145 genes, with more than 20 independent reads. No differences were seen between the 2 versions of the panel. The NGS tool allowed a total of 91 patients to be diagnosed, with an overall molecular diagnostic rate of 44%. Among the 167 patients with classified IBMFSs, 81 patients (48%) were diagnosed. Unclassified IBMFSs involved a total of 37 patients, of whom 9 patients (24%) were diagnosed. The preexisting diagnosis of 6 clinically classified patients (6%) was amended, implying a change of therapy for some of them. Our NGS IBMFS gene panel assay is a useful tool in the molecular diagnosis of IBMFSs and a reasonable option as the first tier genetic test in these disorders.</dc:description>
   <dc:date>2021-07-19T12:51:42Z</dc:date>
   <dc:date>2021-07-19T12:51:42Z</dc:date>
   <dc:date>2021-03-09</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Gálvez E, Vallespín E, Arias-Salgado EG, Sánchez-Valdepeñas C, Giménez Y, Navarro S, et al. Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes. HemaSphere. 2021 Mar 9;5(4):e539.</dc:identifier>
   <dc:identifier>2572-9241</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/6181</dc:identifier>
   <dc:identifier>10.1097/HS9.0000000000000539</dc:identifier>
   <dc:identifier>33718801</dc:identifier>
   <dc:identifier>000639295800001</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>HemaSphere;5(4)</dc:relation>
   <dc:relation>https://journals.lww.com/hemasphere/Fulltext/2021/04000/Next_generation_Sequencing_in_Bone_Marrow_Failure.3.aspx</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Lippincott, Williams &amp; Wilkins</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>